Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors and other biologically active molecules. Its structure supports Suzuki-Miyaura cross-coupling reactions, making it valuable in creating carbon-carbon bonds for drug discovery and medicinal chemistry research. The presence of both boronic acid and ether functionalities allows for selective transformations and improved binding affinity in target molecules. Commonly employed in the preparation of potential treatments for cancer, inflammation, and neurological disorders.